The effect of rosehip supplement consumption on fatty liver
Phase 2
Recruiting
- Conditions
- fatty liver.Fatty (change of) liver, not elsewhere classified Nonalcoholic fatty liver disease [NAFLD]
- Registration Number
- IRCT201410265968N5
- Lead Sponsor
- Brain and Spinal injury Research Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
1.Age between 18 and 70 years 2.Fatty liver disease. Exclusion criteria: 1. Alcohol consumption 2.Smoking 3.taking certain medication, such as blood pressure medications, Insulin sensitivity enhancers, statins, hepatotoxic drugs such as Phenytoin, tamoxifen, lithium and supplements 4. Acute liver disorders such as Hepatitis B and C, liver transplantation, biliary disease known as autoimmune disease, cancer, inherited disorders affecting liver condition (iron and copper storage disease) and other disease 5.Failure to sign the ethical consent.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatty Liver grade. Timepoint: At the baseline and then after 4 months. Method of measurement: sonography.;Liver enzymes, SGOT and SGPT. Timepoint: At the baseline and then after 4 months. Method of measurement: blood test.
- Secondary Outcome Measures
Name Time Method ipid Profile. Timepoint: At the baseline and then after 4 months. Method of measurement: blood test.